The Need for Balanced Health Policies to Avoid Path Dependent Medicine

Document Type: Perspective

Author

Division of Health Studies, School of Health Sciences & Social Care, Brunel University London, Uxbridge, UK

Main Subjects


  • Looking at the past, do you think that health policy arena has been successful to make healthy policies for all human kind?
  • Has the time arrived to move from evidence-based policy making towards needs-based, futuristic, and healthy health policy making?
  • If so, how can we make this shift happening?


Health policy has been intrinsically linked to economic, financial, social, and regional policy. Global efforts and governmental commitments to making healthy public policies and improving health conditions have been phenomenally extensive and comprehensive in the course of the last few decades. The millennium development goals (MDGs) and valuable attempts by international and supranational bodies, i.e. World Health Organization (WHO); World Bank; Global Fund to fight Tuberculosis (TB), Malaria and AIDS; Gates Foundation, to count a few, have been fundamentally exemplar in improving global health, particularly for the poor. After the second world war, particularly in the period of the last 20 years, technological advances have brought magical outcomes to human life. For example, HIV/AIDS was terrifying 10 years ago. Although it is still an international concern and frightening for many nations, recent advances to cure and manage HIV positive patients have been astounding. There are types of cancers that are considered curable today, most of which would have killed people even at the beginning of the millennium. Unfortunately, millions of people still die from conditions such as malaria and TB.

Read more...

1. Gregor M. Bird flu: a virus of our own hatching. Lantern Books; New York: 2006.

2. Smith R, Coast J. The true cost of antimicrobial resistance. BMJ 2013; 346: f1493. doi: http://dx.doi.org/10.1136/bmj.f1493

3. Cars O, Hogberg LD, Murray M, Jasper W, Nordberg O, Sivaraman S, et al. Meeting the challenge of antibiotic resistance. BMJ 2008; 337:726-8. doi: http://dx.doi.org/10.1136/bmj.a1438

4. Bratzer DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-15.

5. Wild SM. Antibiotic prophylaxis at caesarean section. Lancet 2002; 360: 724. doi: 10.1016/S0140-6736(02)09862-8

6. So AD, Ruiz-Esparza Q, Gupta N, Cars O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ 2012: 344: e1782. doi: http://dx.doi.org/10.1136/bmj.e1782

7. Cormican M, Vellinga A. Existing classes of antibiotics are probably the best we will ever have. BMJ 2012; 344: e3369. doi: http://dx.doi.org/10.1136/bmj.e3369

8. Coast J, Smith RD, Millar MR. Disentangling value: assessing the benefits of containing antimicrobial resistance. In: Roberts J, ed. The economics of infectious disease. Oxford University Press; 2006: 201-14.

9. Walshea K, McKeeb M, McCarthyc M, Groenewegend P, Hansene J, Figueras J, et al. Health systems and policy research in Europe: Horizon 2020. Lancet 2013 Mar 15. [In press]

10. World Bank, World Bank annual report, 2012.

11. Heath I. Words are all we have. BMJ 2011; 343: d7166. doi: http://dx.doi.org/10.1136/bmj.d7166

12. Global Forum for Health Research .Monitoring financial flows for health research. Geneva: Global Forum for Health Research. 2004. (cited 2013 May 17) Available at: http://www.globalforumhealth.org

13. Takian A, Petrakaki D, Cornford T, Sheikh A, Barber N. Building a house on shifting sand: Methodological considerations when evaluating the implementation and adoption of national electronic health record systems. BMC Health Serv Res 2012, 12:105. doi: 10.1186/1472-6963-12-105

14. Greenhalgh T, Russell J. Why do evaluation of ehealth programs fail? An alternative set of guiding principles. PLoS Med 2010; 7: e1000360. doi: 10.1371/journal.pmed.1000360

15. European Commission, COM 211(811). Proposal for a council decision establishing the specific programme implementing horizon 2020 —the framework programme for research and innovation (2014–2020). Brussels: European Commission, 2012.

16. Howitt P, Darzi A, Yang G-Z, Ashrafian H, Atun R, Barlow J, et al. Technologies for global health.Lancet 2012; 380: 507-35. doi: 10.1016/S0140-6736(12)61127-1

17. HSR Europe. Health services research into European policy and practice. Utrecht: Netherlands Institute for Health Services Research; 2011.

18. McCarthy M. Public health research—Europe’s future (STEPS report). London: University College London, 2011. (accessed 2013 May 21). Available at: http://discovery.ucl.ac.uk/1329165

19. Takian A, Cornford T. NHS information: Revolution or evolution? Health Policy and Technology 2012; 1: 193-198. doi: 10.1016/j.hlpt.2012.10.005